In this episode of Psychedelics Weekly, David is joined by Kyle, who is finally home after a lot of traveling, to talk shop and dig into the articles they found the most interesting this week.
They begin with the news that Paul Stamets now has a species of mushroom named after him (Psilocybe stametsii), then take a look at a recent self-report study called “Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics,” which aimed to collect data on just how many psychedelic users (in this study, anyone who had ever tried a psychedelic) felt that they had had a challenging or difficult experience. They discuss the results and highlight some interesting data: that LSD was the most commonly associated substance, that smoking cannabis was one of the most commonly reported interventions, and of course, the question of whether or not these experiences were beneficial.
They then talk about Synthesis Institute closing its doors, the possible hope Synthesis could have, and the sadness in this – when businesses fail, it’s easy to look at numbers and profit margins and be dismissive, but we forget the people involved; not just at Synthesis, but the hundreds of would-be students.
And lastly, they look at an article about a California-based startup called the Reality Center, which uses a combination of pulsing lights, sounds, and vibrations to create a drug-free but seemingly very psychedelic experience, reminding us yet again that you do not need a substance to achieve non-ordinary states of consciousness.
Forbes.com: There’s A New Species Of Magic Mushroom – Named After Paul Stamets
Graham Pechenik’s thread about the Stamets Stack becoming patented
Biomedcentral.com: Ketamine can be produced by Pochonia chlamydosporia: an old molecule and a new anthelmintic?
Mushroom.cat: Psilocybe Weilii: Good for Making Magic Mushrooms? Don’t Mistake It With Psilocybe Caerulescens
Psychedelics Today: PT377 – Integrative Medicine: Health, Wellness, and Psychedelics, featuring: Andrew Weil, M.D.
Sciencedirect.com: Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics
Psychedelics Today: PT314 – Daniel McQueen, MA – Vital Psychedelic Conversations
Psychedelicalpha.com: Inside Synthesis Institute’s Implosion
Oregon.gov: Higher Education Coordinating Commission
Stripes.com: A drug-free, digital psychedelic trip
Psychedelics Today: Allison Pelissier – Lucia N°03 Light Experience
Psychedelics Today: PT394 – We Are The Medicine, featuring: Victor Alfonso Cabral, LSW